; (2) to enhance supply chain security related to technology transfer and intellectual property protection; (3) to diversify and expand supplier networks to ensure a reliable supply of medical goods, especially in the event of emergency situations; (4) to eliminate unnecessary trade barriers and distortions that weaken or disrupt medical supply chains; (5) to expedite cross-border movement of critical medical goods; (6) to foster international collaboration, encourage new investments, promote cooperation and partnership in public and private research and development efforts, facilitate data flows for life science research and development, and expand manufacturing capacities for medical devices and pharmaceutical goods; (7) to promote regulatory cooperation with respect to manufacturing of medical goods; (8) to increase access to government procurement markets for medical goods; (9) to encourage adoption of and adherence to good regulatory practices related to medical goods; (10) to enable greater transparency, regulatory harmonization, and reliance in authorization and licensing procedures for medical devices and pharmaceutical goods; (11) to facilitate trade in medical goods to the most efficient and practicable extent possible; and (12) to identify current production capacities, address potential weaknesses, and improve overall resilience. 4. Definitions In this Act: (1) Appropriate committees of Congress The term appropriate committees of Congress means— (A) the Committee on Finance of the Senate; and (B) the Committee on Ways and Means of the House of Representatives. (2) Country The term country means— (A) any foreign country or territory, including any overseas dependent territory or possession of a foreign country